European Journal of Cancer

Title Publication Date Language Citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)2009/01/01English18,517
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 20122013/04/01English3,493
Radiomics: Extracting more information from medical images using advanced feature analysis2012/03/01English3,118
Estimates of cancer incidence and mortality in Europe in 20082010/03/01English1,533
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 20182018/11/01English1,498
Immune-related adverse events with immune checkpoint blockade: a comprehensive review2016/02/01English1,430
Curcumin: The story so far2005/09/01English1,154
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy2006/04/01English1,052
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress1994/01/01English1,052
RECIST 1.1—Update and clarification: From the RECIST committee2016/07/01English1,010
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure2005/01/01English781
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours2011/01/01English742
The role of IL-6 and STAT3 in inflammation and cancer2005/11/01English671
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review2016/04/01English670
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group2010/05/01English646
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours2006/05/01English611
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials1994/01/01English596
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness2009/05/01English585
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary2009/04/01English582
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients2004/10/01English581
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study2011/11/01English540
Role of oxygen free radicals in cancer development1996/01/01English531
Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s2008/07/01English519
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality2012/09/01English514
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi2005/01/01English501
Rare cancers are not so rare: The rare cancer burden in Europe2011/11/01English474
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors2005/09/01English468
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy2016/06/01English464
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project2013/02/01English458
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies2011/09/01English443